TABLE OF CONTENTS

1. INTRODUCTION 22
1.1. OBJECTIVES OF THE STUDY 22
1.2. MARKET DEFINITION 22
1.3. OVERVIEW OF GLOBAL BIOSENSOR MARKET 22
1.4. CURRENCY AND PRICING 23
1.5. LIMITATION 23
1.6. MARKETS COVERED 24
2. MARKET SEGMENTATION 27
2.1. MARKETS COVERED 27
2.2. GEOGRAPHIC SCOPE 28
2.3. YEARS CONSIDERED FOR THE STUDY 29
2.4. CURRENCY AND PRICING 29
2.5. RESEARCH METHODOLOGY 30
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 33
2.7. SECONDARY SOURCES 34
2.8. ASSUMPTIONS 34
3. MARKET OVERVIEW 35
3.1. DRIVERS 37
3.1.1. SIGNIFICANT TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF BIOSENSOR 37
3.1.2. EMERGENCE OF NANOTECHNOLOGY-BASED BIOSENSORS 37
3.1.3. INCREASING USE OF BIOSENSORS TO MONITOR GLUCOSE LEVELS IN INDIVIDUALS WITH DIABETES 37
3.1.4. HIGH DEMAND OF BIOSENSOR IN MONITORING AND DIAGNOSTIC DEVICES 38
3.1.5. RISING DEMAND FOR DISPOSABLE, COST-EFFICIENT, AND USER-FRIENDLY DEVICES 39
3.2. RESTRAINTS 39
3.2.1. SLOW RATE OF COMMERCIALIZATION 39
3.2.2. HIGH COSTS FOR INITIAL DEVELOPMENT 39
3.3. OPPORTUNITIES 40
3.3.1. GROWTH OPPORTUNITY IN ENVIRONMENTAL MONITORING, BIODEFENSE AND FOOD SECTOR 40
3.3.2. RISING DEMAND IN DEVELOPING COUNTRIES 40
3.4. CHALLENGES 41
3.4.1. STRINGENT GOVERNMENT REGULATIONS 41
4. EXECUTIVE SUMMARY 42
5. PREMIUM INSIGHTS 44
6. GLOBAL BIOSENSOR MARKET, BY PRODUCT 47
6.1. OVERVIEW 48
6.2. WEARABLE BIOSENSORS 50
6.2.1. WRISTWEAR 51
6.2.2. EYEWEAR 51
6.2.3. FOOTWEAR 52
6.2.4. BODYWEAR 52
6.2.5. NECKWEAR 52
6.2.6. OTHERS 52
6.3. NON-WEARABLE BIOSENSORS 53
7. GLOBAL BIOSENSOR MARKET, BY APPLICATION 54
7.1. OVERVIEW 55
7.2. POINT OF CARE (POC) 56
7.2.1. GLUCOSE MONITORING 58
7.2.2. INFECTIOUS DISEASES 58
7.2.3. CARDIAC MARKERS 59
7.2.4. PREGNANCY & FERTILITY TESTING 59
7.2.5. TUMOR OR CANCER MARKERS 59
7.2.6. COAGULATION MONITORING 59
7.2.7. URINALYSIS TESTING 59
7.2.8. BLOOD GAS & ELECTROLYTES 59
7.2.9. CHOLESTEROL TESTS 60
7.2.10. OTHERS 60
7.3. HOME DIAGNOSTICS 61
7.4. ENVIRONMENTAL MONITORING 62
7.4.1. WASTEWATER TREATMENT 62
7.5. RESEARCH LABS 63
7.5.1. DRUG DEVELOPMENT 63
7.6. FOOD & BEVERAGES INDUSTRY 64
7.7. BIODEFENCE 65
7.7.1. CRIME DETECTION 66
7.8. OTHERS 66
8. GLOBAL BIOSENSOR MARKET, BY TECHNOLOGY 67
8.1. OVERVIEW 68
8.2. ELECTROCHEMICAL BIOSENSORS 70
8.2.1. AMPEROMETRIC SENSORS 72
8.2.1.1. BLOOD GLUCOSE SENSORS 72
8.2.2. POTENTIOMETRIC SENSORS 73
8.2.2.1. PENICILLIN BIOSENSOR 73
8.2.2.2. IMMUNOSENSORS 73
8.2.2.3. UREA BIOSENSOR 74
8.2.3. CONDUCTOMETRIC SENSORS 74
8.3. OPTICAL BIOSENSORS 75
8.3.1. FLUORESCENCE BIOSENSORS 76
8.3.2. SURFACE PLASMON RESONANCE (SPR) 76
8.3.3. CALORIMETRIC BIOSENSORS 76
8.4. PIEZOELECTRIC BIOSENSORS 77
8.4.1. ACOUSTIC BIOSENSORS 78
8.4.2. MICROCANTILEVER BIOSENSORS 78
8.5. NANOMECHANICAL BIOSENSORS 79
8.6. THERMAL BIOSENSORS 80
8.7. OTHERS 81
9. GLOBAL BIOSENSOR MARKET, BY GEOGRAPHY 82
9.1. OVERVIEW 83
9.2. NORTH AMERICA 90
9.2.1. U.S. 99
9.2.2. CANADA 101
9.2.3. MEXICO 103
9.3. EUROPE 105
9.3.1. GERMANY 114
9.3.2. FRANCE 116
9.3.3. U.K. 118
9.3.4. ITALY 120
9.3.5. SPAIN 122
9.3.6. SWITZERLAND 124
9.3.7. NETHERLANDS 126
9.3.8. TURKEY 128
9.3.9. BELGIUM 130
9.3.10. RUSSIA 132
9.3.11. REST OF EUROPE 134
9.4. ASIA-PACIFIC 135
9.4.1. JAPAN 144
9.4.2. CHINA 146
9.4.3. INDIA 148
9.4.4. SOUTH KOREA 150
9.4.5. AUSTRALIA 152
9.4.6. SINGAPORE 154
9.4.7. THAILAND 156
9.4.8. MALAYSIA 158
9.4.9. INDONESIA 160
9.4.10. PHILIPPINES 162
9.4.11. REST OF ASIA-PACIFIC 164
9.5. SOUTH AMERICA 165
9.5.1. BRAZIL 174
9.5.2. REST OF SOUTH AMERICA 176
9.6. MIDDLE EAST AND AFRICA 177
9.6.1. SOUTH AFRICA 186
9.6.2. REST OF MIDDLE EAST AND AFRICA 188
10. GLOBAL BIOSENSORS MARKET, COMPANY LANDSCAPE 189
10.1. COMPANY SHARE ANALYSIS; GLOBAL 189
10.2. COMPANY SHARE ANALYSIS; NORTH AMERICA 190
10.3. COMPANY SHARE ANALYSIS; EUROPE 191
10.4. COMPANY SHARE ANALYSIS; ASIA-PACIFIC 192
11. COMPANY PROFILES 193
11.1. ABBOTT 193
11.1.1. COMPANY OVERVIEW 193
11.1.2. ABBOTT; REVENUE ANALYSIS 193
11.1.3. PRODUCT PORTFOLIO 195
11.1.4. RECENT DEVELOPMENTS 195
11.2. MEDTRONIC 196
11.2.1. COMPANY OVERVIEW 196
11.2.2. MEDTRONIC; REVENUE ANALYSIS 196
11.2.3. PRODUCT PORTFOLIO 197
11.2.4. RECENT DEVELOPMENTS 197
11.3. JOHNSON & JOHNSON SERVICES, INC. (LIFESCAN, INC.) 198
11.3.1. COMPANY OVERVIEW 198
11.3.2. JOHNSON & JOHNSON SERVICES, INC; REVENUE ANALYSIS 198
11.3.3. PRODUCT PORTFOLIO 199
11.3.4. RECENT DEVELOPMENTS 199
11.4. UNIVERSAL BIOSENSORS INC. 200
11.4.1. COMPANY OVERVIEW 200
11.4.2. UNIVERSAL BIOSENSORS INC.; REVENUE ANALYSIS 200
11.4.3. PRODUCT PORTFOLIO 201
11.4.4. RECENT DEVELOPMENTS 201
11.5. DU PONT 202
11.5.1. COMPANY OVERVIEW 202
11.5.2. DUPONT; REVENUE ANALYSIS 202
11.5.3. PRODUCT PORTFOLIO 203
11.5.4. RECENT DEVELOPMENTS 203
11.6. SYSMEX CORPORATION 204
11.6.1. COMPANY OVERVIEW 204
11.6.2. SYSMEX CORPORATION; COMPANY SNAPSHOT 204
11.6.3. PRODUCT PORTFOLIO 205
11.6.4. RECENT DEVELOPMENTS 205
11.7. BIO-RAD LABORATORIES, INC. 206
11.7.1. COMPANY OVERVIEW 206
11.7.2. BIO-RAD LABORATORIES, INC.; REVENUE ANALYSIS 206
11.7.3. PRODUCT PORTFOLIO 207
11.7.4. RECENT DEVELOPMENTS 207
11.8. PHARMACO-KINESIS 208
11.8.1. COMPANY OVERVIEW 208
11.8.2. PHARMACO-KINESIS ; COMPANY SNAPSHOT 208
11.8.3. PRODUCT PORTFOLIO 209
11.8.4. RECENT DEVELOPMENTS 209
11.9. NOVA BIOMEDICAL 210
11.9.1. COMPANY OVERVIEW 210
11.9.2. NOVA BIOMEDICAL; COMPANY SNAPSHOT 210
11.9.3. PRODUCT PORTFOLIO 211
11.9.4. RECENT DEVELOPMENTS 211
11.10. ACON LABORATORIES, INC. 212
11.10.1. COMPANY OVERVIEW 212
11.10.2. ACON LABORATORIES, INC.; COMPANY SNAPSHOT 212
11.10.3. PRODUCT PORTFOLIO 212
11.10.4. RECENT DEVELOPMENTS 213
11.11. GENERAL ELECTRIC 214
11.11.1. COMPANY OVERVIEW 214
11.11.2. GENERAL ELECTRIC; REVENUE ANALYSIS 214
11.11.3. PRODUCT PORTFOLIO 215
11.11.4. RECENT DEVELOPMENTS 215
11.12. XSENSIO 216
11.12.1. COMPANY OVERVIEW 216
11.12.2. XSENSIO; COMPANY SNAPSHOT 216
11.12.3. PRODUCT PORTFOLIO 216
11.12.1. RECENT DEVELOPMENTS 216
11.13. HMICRO INC. 217
11.13.1. COMPANY OVERVIEW 217
11.13.2. HMICRO INC.; COMPANY SNAPSHOT 217
11.13.3. PRODUCT PORTFOLIO 217
11.13.4. RECENT DEVELOPMENTS 217
?
11.14. ERCON INC. 218
11.14.1. COMPANY OVERVIEW 218
11.14.2. ERCON INC.; COMPANY SNAPSHOT 218
11.14.3. PRODUCT PORTFOLIO 219
11.14.4. RECENT DEVELOPMENTS 219
11.15. DRaGERWERK AG & CO. KGAA 220
11.15.1. COMPANY OVERVIEW 220
11.15.2. DRaGERWERK AG & CO. KGAA; REVENUE ANALYSIS 220
11.15.3. PRODUCT PORTFOLIO 221
11.15.4. RECENT DEVELOPMENTS 221
11.16. DANAHER(MOLECULAR DEVICES, LLC) 222
11.16.1. COMPANY OVERVIEW 222
11.16.2. DANAHER(MOLECULAR DEVICES, LLC); REVENUE ANALYSIS 222
11.16.3. PRODUCT PORTFOLIO 223
11.16.4. RECENT DEVELOPMENTS 223
12. RELATED REPORTS 224